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Association between First Trimester Pregnancy Associated Plasma Protein–A 
(PAPP-A) and Gestational Diabetes Mellitus Development 
Background 
 
Conclusions 
 
 
 
 
 
 
 
 
 
 
 
u  Affecting 5-6% of pregnancies, Gestational 
Diabetes (GDM) is a common pregnancy 
complication with significant cardiometabolic 
consequences for mothers and offspring.  
 
u  Previous research from our group suggests that 
adipose tissue IGFBP-5 and the metalloprotease 
PAPP-A (Pregnancy Associated Plasma Protein-
A) may play a mechanistic role in GDM 
development by regulating functional IGF-1 levels 
and lipid storage and metabolism.  
Objective 
To examine the relationship between circulating PAPP-
A levels and GDM development. We hypothesized that 
high first trimester PAPP-A levels would be associated 
with decreased GDM risk.  
Methods 
u  Retrospective cohort from EMR data of 1,251 women delivering singleton gestations during the years 2009, 2010, 2014 and 2015  
u  PAPP-A was measured in the first trimester (11-14 weeks) as part of routine aneuploidy screen, and reported as quartiles of multiples of 
the mean (MoM) based on gestational age and adjusted for maternal weight and race/ethnicity.  
u  GDM diagnosis was based on a standard 2-step protocol (~24-28 weeks; failed 50g 1hr glucola screen followed by ≥2 abnormal values 
per Carpenter-Coustan criteria on 100g 3hr glucose tolerance test).  
u  Crude and multivariable-adjusted logistic regression models estimated the association between PAPP-A MoM quartiles and GDM.  
u  Higher PAPP-A MoM levels were associated with lower GDM risk.  
 
u  Future studies should assess whether higher PAPP-A levels are associated with 
enhanced IGF-1 signaling and improved pregnancy metabolic homeostasis.  
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Figure: Incident gestational diabetes mellitus (GDM) in 
relation to first-trimester PAPP-A, pre-pregnancy BMI, and 
age, OR (95% CI) 
Results  
Figure. In normal pregnancy, induction of IGFBP-5 
increases the amount of sequestered IGF-1 and IGF-2 
and PAPP-A degrades IGFBP-5 to release IGFs which in 
turn promote angiogenesis and hyperplastic expansion. In 
women with GDM, insufficient levels of IGFBP-5 and 
possibly decreased levels of PAPP-A, lead to decreased 
bioavailability of IGF which prevents proper angiogenesis 
resulting in adipocyte hypertrophy and decreased 
capillary density.  
Conceptual framework of the role of 
adipose tissue and development of 
GDM 
 
 
u  Adjusting for pre-pregnancy BMI, nuchal translucency, crown rump length, smoking 
status, and parity, women with PAPP-A MoM in 2nd, 3rd, and 4th quartiles had 52% 
(OR=0.48, 95%CI=0.26-0.88), 45% (OR=0.55, 95%CI=0.30-0.99) and 73% (OR=0.27, 
95%CI=0.13-0.53) lower odds of developing GDM vs women in the 1st quartile. 
u  7.6% (n=95) of 
women develop-
ed GDM. 
 
u  Median PAPP-A 
M o M l e v e l s 
were 0.7 (inter-
quartile range 
[IQR]=0.5-1.0) 
among women 
with GDM & 0.9 
( IQR=0.6-1.3) 
among women 
w h o d i d n o t 
develop GDM. 
  
Normal 
(N=1,156) GDM (N=95) 
  N N 
Age at lab visit 
(mean, SD) 29.5 (5.7) 32.4 (5.0) 
Gestational age at 
lab visit (mean, 
SD) 
12.5 (0.6) 12.4 (0.5) 
Pre-Pregnancy 
BMI     
Normal weight 615 (53%) 24 (25%) 
Overweight 317 (27%) 32 (34%) 
Obese 224 (19%) 39 (41%) 
Cigarette smoker   
No 1019 (88%) 87 (91%) 
Smoker 76 (7%) 2 (2%) 
Parity   
Nulliparous 473 (41%) 26 (27%) 
Multiparous 683 (59%) 69 (73%) 
Crown Rump 
Length (median, 
p25,p75) 
1.3               
(1.1, 1.6) 
1.3              
(1.1, 1.7) 
Nuchal 
Transulency 
(median, p25,p75) 
6.5               
(5.7, 55.7) 
6.4              
(5.6, 50.5) 
